Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Metal Implants and Medical Alloys Market CAGR of 8.6%by 2028, Size, Share, Growth Opportunities, Driver, Restraints and Revenue Insights

Published

on

<!– Name:DistributionId Value:8778128 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1244655 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:a2fea628-4e8b-44f2-8de9-e314a81cdaa0 –>

Luton, Bedfordshire, United Kingdom, Feb. 28, 2023 (GLOBE NEWSWIRE) —

Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed and published the final copy of the detailed research report on the Metal Implants and Medical Alloys Market.

Global Metal Implants and Medical Alloys Market stands at US$ 2.83 Billion in 2022 and is anticipated to grow at a CAGR of 8.6% over the following Six years to reach US$ 4.4 billion by 2028.

Metal Implants and Medical Alloys Market Growth in upcoming years

Metal implants do not have any osteogenic qualities to aid in bone repair; they are only biocompatible. CaP coatings enhance their osteointegration or biological anchoring to the bone. It is intended to give metal implants surface biological characteristics for protein adsorption, cell adhesion, and bone apposition. Instead of fibrous tissue encapsulation, direct bone-to-implant contact is preferred for a biomechanical fixation of implants.

Metal implants have greatly improved the quality of life for millions of patients by making procedures like spinal surgery, joint replacement, and fracture fixation possible. Metal implants as biocompatible surfaces inside a bony habitat have many advantages and disadvantages. We concentrate on how they engage with bone and the circumstances that allow pathogens to colonize them. Bacterial adhesion is generally encouraged by any surface that can encourage extracellular matrix molecule attachment to increase osteoblast cell number and, consequently, osseointegration.

Click & Get Free Sample Report in Minutes: https://exactitudeconsultancy.com/reports/1434/metal-implants-and-medical-alloys-market/#request-a-sample 

 Market Dynamics

Driver: Growing demand for minimally invasive surgical procedures

Minimally invasive surgical procedures are performed for a broad range of conditions such as herniated discs, degenerative spinal disease, fractures, trauma, tumors, herniated discs with cord compression, herniated discs with Cauda Equina Syndrome (CES), spondylosis/spondylolisthesis, stenosis, pseudoarthrosis, partial knee trauma, and errors in the positioning of prosthetic implants.

Compared to open surgeries, minimally invasive surgical techniques are safer, less traumatic, and have reduced mortality and complication rates. A study by Clinical Orthopedics and Related Research found that open operations have a 5.77 times higher chance of surgical-site infections (SSIs) than minimally invasive procedures. Reduced surgical risk, less discomfort and blood loss, a lower risk of infection, and shorter post-operative recovery times are just a few benefits of minimally invasive procedures.

Restraint: Shortage of skilled surgeons

The Lancet Commission on Global Surgery estimates that each year in low- and middle-income nations (LMICs), an additional 2.2 million surgeons, anesthetists, and obstetricians are needed. Additionally, there is a shortage of surgeons in the healthcare systems of key healthcare markets like the US, Germany, and the UK. For instance, the Association of American Medical Colleges estimates that by 2025, there will be a shortage of 41,000 general surgeons in the US, while there is one vascular surgeon for every 137,000 people in the UK. Despite having a sizable target patient group, the significant lack of surgeons capable of handling the rising demand for procedures is anticipated to have an impact on the uptake of implants in the years to come.

Companies Covered:

  • Carpenter Technology Corporation
  • Royal Dsm
  • Johnson Matthey PLC
  • Fort Wayne Metals
  • ATI Specialty Alloys & Components
  • Ametek Specialty Metal Products
  • Questek Innovations LLC
  • Supra Alloys Inc
  • Materion Corporation
  • Aperam S.A

Recent Developments

  • June 2022: OsssDsign announced that the company launched of OssDsign Cranial PSI in Japan. OssDsign Cranial PSI is a patient-specific cranial implant made from 3D-printed medical-grade titanium covered by a regenerative calcium phosphate composition.
  • March 2022: OSSIO Inc. achieved another significant commercial milestone with its third regulatory clearance from the United States Food and Drug Administration (FDA) for the OSSIOfiber product family in the last four months, paving the way for additional implants made from OSSIOfiber Intelligent Bone Regeneration Technology to be available to patients and surgeons over the next six months.
Attributes Value
Metal Implants and Medical Alloys market Share (2022) US$ 2.83 Billion
Metal Implants and Medical Alloys market Projected Size (2028) US$ 4.4 Billion
Metal Implants and Medical Alloys market Growth (CAGR 2023-2028) 8.6%.

Browse the fullMetal Implants and Medical Alloys Market By type (Titanium, Stainless Steel, cobalt-Chromium, Other metals), by application (Orthopedic, Cardiovascular, Dental, Craniomaxillofacial and Neurological) and by Region, Global trends and forecast from 2023 to 2028Report and TOC at https://exactitudeconsultancy.com/reports/1434/metal-implants-and-medical-alloys-market/#table-of-content   
Segment Overview

The Metal Implants and Medical Alloys market is segmented by type, deployment, and end user.

by Type  by Application by Region
  • Titanium
  • Stainless Steel
  • Cobalt-Chromium
  • Others (Gold, Silver And Magnesium Alloys)
  • Orthopedic
  • Cardiovascular
  • Dental
  • Craniomaxillofacial
  • Neurological

 

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East and Africa

 

To learn more about this report, request a free sample copy

Market Trends

Dental Segment Expected to Hold a Major Market Share in the Metal Implants and Medical Alloys Market

Artificial tooth roots known as dental implants can be medically inserted into the jawbone. The fixture and the abutment, which are usually made of zirconium and titanium, are the two main parts of dental implants. The country’s rising dental problem burden and the nation’s aging populace are fueling segment development. According to a research report published in the International Dental Journal in August 2022, oral diseases continued to be a significant health concern for local Chinese citizens in Jiangsu. The demand for dental implants is anticipated to increase throughout the study period as a result of the high prevalence of dental issues in the nation.

Quantitative Analysis

  • Market size, estimates, and forecasts from 2023 – 2028
  • Market size and revenue estimates for product up to 2028
  • Market revenue estimates for application up to 2028
  • Market revenue estimates for type up to 2028
  • Regional market size and forecast up to 2028
  • Company financial

What are the Key Data Covered in this Metal Implants and Medical Alloys Market Report?

  • CAGR of the market during the forecast period 2023-2028
  • Detailed information on factors that will drive Metal Implants and Medical Alloys Market growth during the next Six years
  • Precise estimation of the Metal Implants and Medical Alloys Market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behaviour
  • The growth of the Metal Implants and Medical Alloys industry across North America, Europe, APAC, South America, the Middle East, and Africa
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of Metal Implants and Medical Alloys Market vendors

To know an additional revised 2023 list of market players, request a sample report: https://exactitudeconsultancy.com/reports/1434/metal-implants-and-medical-alloys-market/#request-a-sample 
 Browse Other Related Research Reports from Exactitude Consultancy

Sleep Apnea Devices Market -> Market is projected to reach $ 11.3 billion by 2028-Request an PDF Sample [139-Pages]

Medical Aesthetics Market-> Market is projected to reach $ 15.8 billion by 2028-Request an PDF Sample [140-Pages]

Respiratory Care Devices Market-> Market is projected to reach $ 32.5 Billion by 2028-Request an PDF Sample [139-Pages]

Pet Insurance Market-> Market is projected to reach $ 17 billion by 2026-Request an PDF Sample [85-Pages]


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading

Trending